▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Keith Speights

TMFFishBiz

Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services

Keith Speights

Recent Articles by Keith Speights

Why Viking Therapeutics Stock Is Skyrocketing Today

Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?

Trump Stands to Make $3.9 Billion From Digital World Acquisition's Merger With Trump Media & Technology Group. Is the Stock a No-Brainer Buy?

Gartner Predicts a 25% Search Traffic Decline by 2026. Should Investors Avoid Google Stock Like the Plague?

3 Ultra-High-Yield Dividend Stocks That Could Realistically Double Your Money by 2030

Meet a $496 Billion Artificial Intelligence (AI) Stock That's Not in the "Magnificent Seven"

Cathie Wood Is Selling This High-Yield Dividend Stock. Should You?

59% of This Vanguard ETF Is Invested in the "Magnificent Seven" Stocks. Is It a No-Brainer Buy Right Now?

Don't Want the Headaches of Owning Rental Property? Investing $30,000 in These Dividend Stocks Could Make You Nearly $2,000 in Passive Income.

Warren Buffett's Berkshire Hathaway Owns Over 25% of These 4 Companies (Hint: Apple Isn't One of Them)

Should You Buy Chipotle Stock Before Its Ginormous 50-for-1 Stock Split?

Here's 1 Irrefutable Reason Nvidia's Stock Gains Will Slow Dramatically

Should You Buy Reddit Stock After Its Sizzling IPO?

1 Beaten-Down S&P 500 Dividend King to Buy and Hold Forever

Buying These Dirt-Cheap Stocks Could Be a Brilliant Move

How Would Joe Biden and Donald Trump's Social Security Plans Affect Your Retirement Benefits?

Where Will Viking Therapeutics Stock Be in 10 Years?

Here Are the Only "Magnificent Seven" Stocks Billionaires Warren Buffett and David Tepper Both Own

A Bull Market Is Here: 2 Magnificent Stocks Down 30% or More to Buy Right Now

Will Pfizer Be a Trillion-Dollar Stock by 2035?

Premium Investing Services